| Prev Close | 6.12 |
| Day Low/High | 6.00 / 6.19 |
| 52 Wk Low/High | 3.61 / 8.37 |
| Avg Volume | 1.68M |
| Exchange | NASDAQ |
| Shares Outstanding | 69.99M |
| Market Cap | 428.31M |
| EPS | -0.60 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Short Interest Increases 10% For PGNX
The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 930,934 share increase in total short interest for Progenics Pharmaceuticals, Inc. , to 10,136,448, an increase of 10.11% since 07/29/2016.
4 Biotech Stock Charts You Must See
Biotech stocks dominate our list of top charts today. Here are four to watch.
Progenics Receives $50 Million Milestone Payment Following FDA Approval Of RELISTOR® Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-cancer Pain
Company Eligible to Receive Up to $200 Million of Sales Milestone Payments and Ongoing Sales Royalties
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Following Galenica's $1.5 billion bid for Relypsa, investors are beginning to search for the next target.
Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock
Trade-Ideas LLC identified Progenics Pharmaceuticals (PGNX) as a "perilous reversal" (up big yesterday but down big today) candidate
Dow Closes at Record High for 7th Straight Session as Microsoft Surges
The Dow Jones Industrial Average clocks its seventh straight record closing Wednesday amid better-than-expected earnings from Microsoft, the best performing stock in the blue-chip index.
These 3 Stocks Are Rising on Big Volume -- Is It Time to Buy?
Here's a look at how to trade some of the most active stocks on the market right now.
S&P 500, Dow on Track to Break Records as Microsoft Surges
Stocks are at record intraday highs by mid-afternoon Wednesday as crude oil trades above $45 and positive quarterly results for Microsoft spread earnings season cheer.
Midday Report: Valeant Jumps on FDA Approval; Dow at Records
Stocks moved higher, boosted by a series of earnings reports from the likes of Microsoft, Morgan Stanley and United Continental.
Progenics (PGNX) Stock Soars as Relistor Receives FDA Approval
Progenics (PGNX) stock is spiking today after the FDA approved its Relistor treatment for constipation.
Stocks Move Higher as Crude Pares Losses
Stocks move higher on Wednesday after a weekly reading on crude oil inventories confirms declining supplies.
Dow on Track for Another Record Open as Microsoft Surges
Stock futures climb on Wednesday as better-than-expected earnings from Microsoft push the stock higher in premarket trading.
Heavy Early Morning Activity On Progenics Pharmaceuticals (PGNX)
Trade-Ideas LLC identified Progenics Pharmaceuticals (PGNX) as a pre-market mover with heavy volume candidate
Futures Point Downward for U.S. Markets as Asia Opens Lower
Investors are beginning to wonder if earnings season can support the latest records.
Valeant And Progenics Announce FDA Approves RELISTOR® Tablets For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-cancer Pain
Sales of RELISTOR tablets are expected to commence in the Third Quarter 2016
Progenics Pharmaceuticals (PGNX) Stock: Weak On High Volume Today
Trade-Ideas LLC identified Progenics Pharmaceuticals (PGNX) as a weak on high relative volume candidate
Interesting PGNX Put And Call Options For September 16th
Investors in Progenics Pharmaceuticals, Inc. saw new options begin trading today, for the September 16th expiration.
Trade-Ideas: Progenics Pharmaceuticals (PGNX) Is Today's Strong On High Relative Volume Stock
Trade-Ideas LLC identified Progenics Pharmaceuticals (PGNX) as a strong on high relative volume candidate
3 Stocks on my Brexit Shopping List
Doing some incremental buying in names hit by the selloff with little U.K. exposure.
